Related Experiment Video

Updated: Sep 23, 2025

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.3K

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression

Amber B Jones1, Abbey Rocco2, Lawrence S Lamb3

  • 1Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

Cancers
|May 14, 2022
PubMed

Insights

Cellular stress alters immune signaling, affecting natural killer group 2 member D (NKG2D) ligand expression. Understanding NKG2D ligand regulation in cancer is key for developing targeted immunotherapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Signaling

Background:

  • Cellular distress disrupts homeostatic signaling pathways.
  • Stressors typically increase natural killer group 2 member D (NKG2D) ligand expression for immune cell recognition.
  • NKG2D ligand presence influences disease progression and immunotherapy efficacy.

Purpose of the Study:

  • To review regulatory mechanisms of NKG2D ligand induction and repression in cancer.
  • To highlight current therapeutic strategies targeting NKG2D ligand expression.
  • To provide perspectives for advancing NKG2D ligand biology research.

Main Methods:

  • Literature review of existing research on NKG2D ligand regulation in cancer.
  • Analysis of distinct regulatory mechanisms in tumor cells.
  • Synthesis of current therapeutic approaches and future considerations.

Main Results:

  • Cancer cells exhibit unique regulatory mechanisms for NKG2D ligands, impacting tumor progression.
  • NKG2D ligand expression is a critical factor in immune surveillance and evasion.
  • Targeting stress response pathways offers potential for novel cancer therapies.

Conclusions:

  • A comprehensive understanding of NKG2D ligand regulation is crucial for cancer immunotherapy development.
  • Exploiting cellular stress responses can enhance the efficacy of treatments targeting NKG2D ligands.
  • Further research into NKG2D ligand biology is needed to optimize therapeutic strategies.
Keywords:
NKG2D ligandscancerimmunotherapystress

More Related Videos

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.5K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

542

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.9K